ND

Active Director Director DIN 10298002
DIN 10298002 First appointment Feb 2024 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Neha Dey

Data last updated:

Neha Dey is a Director at Geneser Pharmaceuticals Private Limited (since 2024). The company operates in Food And Beverages. Geneser Pharmaceuticals Private Limited reported revenue of ₹14.3 Lakh (FY 2024).

DIN 10298002
Primary Designation Director
Industry Food And Beverages
First Appointment 05 Feb 2024
Oldest Company Age 7 yrs
Largest company Geneser Pharmaceuticals Private Limited · ₹14.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Feb 20242019₹14.3 Lakh (FY 2024)Active

Board colleagues of Neha Dey

NameDINCompanyDesignation
Akhilesh Kumar Gautam08576445Geneser Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Geneser Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neha Dey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Dey

Neha Dey currently holds 1 directorship: Geneser Pharmaceuticals Private Limited (Director, since 05 Feb 2024, revenue ₹14.3 Lakh (FY 2024)).

Neha Dey was first appointed on 05 Feb 2024 as Director at Geneser Pharmaceuticals Private Limited.

The current boards of Neha Dey's companies include Akhilesh Kumar Gautam (Geneser Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available